These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 15744525)
21. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome. Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259 [TBL] [Abstract][Full Text] [Related]
22. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS. Reid GA; Sahota DS; Sarhan M Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545 [TBL] [Abstract][Full Text] [Related]
23. Exfoliation syndrome. Lin YJ; Wang TH; Kao SC; Hung PT J Formos Med Assoc; 1996 Mar; 95(3):263-6. PubMed ID: 8857263 [TBL] [Abstract][Full Text] [Related]
24. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients. Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424 [TBL] [Abstract][Full Text] [Related]
25. Association of Cogan-Reese syndrome, exfoliation syndrome, and secondary open-angle glaucoma. Holló G; Kóthy P; Konstas AG Eur J Ophthalmol; 2012; 22(1):117-20. PubMed ID: 22167551 [TBL] [Abstract][Full Text] [Related]
26. A short term study of the additive effect of timolol and brimonidine on intraocular pressure. Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886 [TBL] [Abstract][Full Text] [Related]
27. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241 [TBL] [Abstract][Full Text] [Related]
28. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616 [TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open-angle glaucoma. Simsek T; Yanik B; Conkbayir I; Zilelioglu O J Ocul Pharmacol Ther; 2006 Apr; 22(2):79-85. PubMed ID: 16722793 [TBL] [Abstract][Full Text] [Related]
30. Glaucoma and visual outcome in central retinal vein occlusion. Moisseiev J; Desatnik H; Cohen Y; Lusky A; Melamed S Acta Ophthalmol Scand; 1996 Aug; 74(4):368-71. PubMed ID: 8883553 [TBL] [Abstract][Full Text] [Related]
31. [Latanoprost topical ophthalmic combinations]. Călugăru M; Călugăru D Oftalmologia; 2004; 48(4):18-28. PubMed ID: 15782758 [TBL] [Abstract][Full Text] [Related]
34. Short-term effects of brimonidine/timolol and dorzolamide/timolol on ocular perfusion pressure and blood flow in glaucoma. Siesky B; Harris A; Ehrlich R; Cantor L; Shoja MM; Rusia D; Hollander DA; Abrams L; Williams JM; Shoshani Y Adv Ther; 2012 Jan; 29(1):53-63. PubMed ID: 22246943 [TBL] [Abstract][Full Text] [Related]
35. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination. Akman A; Cetinkaya A; Akova YA; Ertan A Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958 [TBL] [Abstract][Full Text] [Related]
36. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S; Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146 [TBL] [Abstract][Full Text] [Related]
37. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Wittström E; Ponjavic V; Lövestam-Adrian M; Larsson J; Andréasson S Acta Ophthalmol; 2010 Feb; 88(1):86-90. PubMed ID: 19432876 [TBL] [Abstract][Full Text] [Related]
38. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Konstas AG; Maltezos A; Bufidis T; Hudgins AG; Stewart WC Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105 [TBL] [Abstract][Full Text] [Related]
39. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Hayreh SS; Zimmerman MB; Beri M; Podhajsky P Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725 [TBL] [Abstract][Full Text] [Related]
40. Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes. Thomas R; Parikh R; Muliyil J; George R; Paul P; Abraham LM Indian J Ophthalmol; 2003 Jun; 51(2):123-8. PubMed ID: 12831141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]